Literature DB >> 21112755

Interaction between dendritic cells and T cells during peripheral virus infections: a role for antigen presentation beyond lymphoid organs?

Sammy Bedoui1, Thomas Gebhardt.   

Abstract

Effective viral immunity depends on the activation of T cells by professional antigen presenting cells, such as dendritic cells (DC). The remarkable heterogeneity of the DC network allows the immune system to respond specifically to various infection strategies by different viruses. As a consequence, DC-T cell interactions resulting in optimal virus-specific T cell priming are highly flexible and involve different types of DC. Further highlighting this complexity, recent lines of evidence suggest that presentation of viral antigen by DC is not only restricted to lymphoid organs, but instead also occurs at peripheral sites of infection. Here we discuss the multifaceted interactions between DC and T cells during peripheral virus infections in both lymphoid organs and the periphery.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21112755     DOI: 10.1016/j.coi.2010.11.001

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  13 in total

1.  Dendritic cell-based vaccines in treating recurrent herpes labialis: Results of pilot clinical study.

Authors:  Olga Leplina; Nataliya Starostina; Olga Zheltova; Alexandr Ostanin; Ekaterina Shevela; Elena Chernykh
Journal:  Hum Vaccin Immunother       Date:  2016-07-26       Impact factor: 3.452

Review 2.  T cell responses during influenza infection: getting and keeping control.

Authors:  Taeg S Kim; Jie Sun; Thomas J Braciale
Journal:  Trends Immunol       Date:  2011-03-23       Impact factor: 16.687

3.  Dendritic cell activation and memory cell development are impaired among mice administered medroxyprogesterone acetate prior to mucosal herpes simplex virus type 1 infection.

Authors:  Rodolfo D Vicetti Miguel; Robert L Hendricks; Alfredo J Aguirre; Melissa A Melan; Stephen A K Harvey; Tracy Terry-Allison; Anthony J St Leger; Angus W Thomson; Thomas L Cherpes
Journal:  J Immunol       Date:  2012-08-31       Impact factor: 5.422

4.  The effect of human immunodeficiency virus-1 on monocyte-derived dendritic cell maturation and function.

Authors:  P Fairman; J B Angel
Journal:  Clin Exp Immunol       Date:  2012-10       Impact factor: 4.330

Review 5.  CD8(+) T cells: foot soldiers of the immune system.

Authors:  Nu Zhang; Michael J Bevan
Journal:  Immunity       Date:  2011-08-26       Impact factor: 31.745

Review 6.  Peripheral regulation of T cells by dendritic cells during infection.

Authors:  Emily A Hemann; Kevin L Legge
Journal:  Immunol Res       Date:  2014-08       Impact factor: 4.505

7.  Nodular inflammatory foci are sites of T cell priming and control of murine cytomegalovirus infection in the neonatal lung.

Authors:  Felix R Stahl; Katrin Heller; Stephan Halle; Kirsten A Keyser; Andreas Busche; Anja Marquardt; Karen Wagner; Jasmin Boelter; Yvonne Bischoff; Elisabeth Kremmer; Ramon Arens; Martin Messerle; Reinhold Förster
Journal:  PLoS Pathog       Date:  2013-12-12       Impact factor: 6.823

8.  Distinct APC subtypes drive spatially segregated CD4+ and CD8+ T-cell effector activity during skin infection with HSV-1.

Authors:  Bethany L Macleod; Sammy Bedoui; Jyh Liang Hor; Scott N Mueller; Tiffany A Russell; Natasha A Hollett; William R Heath; David C Tscharke; Andrew G Brooks; Thomas Gebhardt
Journal:  PLoS Pathog       Date:  2014-08-14       Impact factor: 6.823

Review 9.  The Role of Invariant Natural Killer T Cells in Dendritic Cell Licensing, Cross-Priming, and Memory CD8(+) T Cell Generation.

Authors:  Catherine Gottschalk; Elisabeth Mettke; Christian Kurts
Journal:  Front Immunol       Date:  2015-07-28       Impact factor: 7.561

Review 10.  Every breath you take: the impact of environment on resident memory CD8 T cells in the lung.

Authors:  Hillary L Shane; Kimberly D Klonowski
Journal:  Front Immunol       Date:  2014-07-08       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.